Head to head for first-timers
CoreAge Rx vs MultiMedRx
CoreAge Rx and MultiMedRx both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
CoreAge Rx
Higher scoreRank #31 for first-timers · Grade C
Mama-Match
Best for: Someone comparing dose prices who can obtain the offer, state availability and order terms in writing.
Visit CoreAge RxMultiMedRx
Rank #316 for first-timers · Grade C
Mama-Match
Best for: There is no way to say without a medication price, and the site does not give one.
Visit MultiMedRxThe verdict for a first step
CoreAge Rx edges out MultiMedRx on the Mama-Match Score, 73 to 35 (C vs C). Someone comparing dose prices who can obtain the offer, state availability and order terms in writing.
MultiMedRx is still a genuine option — there is no medication price on this site. The $100 is "the $100 fully refundable consultation fee" and the "$45 to start" is an entry promotion; the program fee — the one that actually pays for the medication — is described in the FAQ and never stated. What it does say clearly is the billing period: the "(4-Week monthly) program fee", four weeks and monthly in the same phrase, which is thirteen charges a year rather than twelve. And if you ask about states, it sends you to the intake form. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | CoreAge Rx | MultiMedRx |
|---|---|---|
| Mama-Match Score | 73/100 · C | 35/100 · C |
| Overall rank | #31 | #316 |
| Semaglutide | $99/mo | No medication price published at all |
| Tirzepatide | $149/mo | No medication price published at all |
| Coverage | Therapy-specific state restrictions; confirm eligibility | Refuses to publish it: "complete the patient intake form" |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Mama-Match
CoreAge Rx
Rank #31 · Grade C
What we like
- Published prices for both molecules, with the same advertised amount at each dose
- The offer includes medication, consultation and shipping, without an advertised membership fee
- The legal footer identifies the platform and the entities responsible for clinical care
The caveats
- The main site and a separate offer page show different prices
- The FAQ and policy differ on automatic rebilling and denial refunds
- State restrictions; orders become final when sent to pharmacy, with a 30-day refund cutoff
Mama-Match
MultiMedRx
Rank #316 · Grade C
What we like
- The $100 consultation fee is described as fully refundable, and said up front
- It does say what the program fee covers: medication "up to 10ml for Tirzepatide and 2.5 for Semaglutide"
- "You don't need to sign a long-term contract", with a one-month option
The caveats
- No medication price appears anywhere: the program fee is described but never stated
- The $100 is a consultation fee and the $45 a promotion; neither is a monthly cost
- The billing period is four weeks, not a month — its own phrase is "(4-Week monthly) program fee", so thirteen cycles a year
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and MultiMedRx with the other providers we review for women.
Or browse the full comparison hub.